PSYCHOSIS IN THE ELDERLY AN INTERACTIVE CASE-BASED TUTORIAL



Similar documents
Conjoint Professor Brian Draper

ASSESSMENT AND MANAGEMENT OF PSYCHOSIS IN PERSONS WITH DEMENTIA

Clinical Audit: Prescribing antipsychotic medication for people with dementia

Chapter 18 Drugs Used for Psychoses Learning Objectives Identify signs and symptoms of psychotic behavior Describe major indications for the use of

Emergency Room Treatment of Psychosis

Dementia & Movement Disorders

DEPRESSION CARE PROCESS STEP EXPECTATIONS RATIONALE

Psychotic Disorder. Psychosis. Psychoses may be caused by: Examples of Hallucinations and Delusions 12/12/2012

These guidelines are intended to support General Practitioners in the care of their patients with dementia both in the community and in care homes.

BIPOLAR DISORDER IN THE ELDERLY

Antipsychotic drug prescription for patients with dementia in long-term care. A practice guideline for physicians and caregivers

Understanding Antipsychotic Medications

Psychotic Disorders , The Patient Education Institute, Inc. mhff0101 Last reviewed: 01/10/2013 1

COMPREHENSIVE MANAGEMENT OF THE ELDERLY PATIENT WITH MANIA

A Manic Episode is defined by a distinct period during which there is an abnormally and persistently elevated, expansive, or irritable mood.

Depression Flow Chart

Psychotic Disorders. Goals. Goals continued. Goals continued. What is Psychosis? Where does it occur? Provide a working definition for psychosis

I. The Positive Symptoms...Page 2. The Negative Symptoms...Page 2. Primary Psychiatric Conditions...Page 2

Preferred Practice Guidelines Bipolar Disorder in Children and Adolescents

Depression is a common biological brain disorder and occurs in 7-12% of all individuals over

Mental Health Needs Assessment Personality Disorder Prevalence and models of care

An Introduction to Lewy Body Dementia

Mental Health Ombudsman Training Manual. Advocacy and the Adult Home Resident. Module V: Substance Abuse and Common Mental Health Disorders

DEMENTIA EDUCATION & TRAINING PROGRAM

prodromal premorbid schizophrenia residual what are the four phases of schizophrenia describe the Prodromal phase of schizophrenia

Recognition and Treatment of Depression in Parkinson s Disease

Fax # s for CAMH programs and services

Antipsychotics in people with dementia an update and reminder

Bipolar Disorder. Mania is the word that describes the activated phase of bipolar disorder. The symptoms of mania may include:

Summary of the risk management plan (RMP) for Aripiprazole Pharmathen (aripiprazole)

Contemporary Psychiatric-Mental Health Nursing. Assessing the Effectiveness of Medications. Administering Medications

Long Term Care Formulary HCD Anti-Dementia Drugs (e.g. donepezil, galantamine, rivastigmine, memantine)

How To Treat Aphasic Depression

Mental health issues in the elderly. January 28th 2008 Presented by Éric R. Thériault

Depression in Older Persons

Guidelines for the Diagnosis and Management of Acute Confusion (delirium) in the Elderly

Understanding tardive dyskinesia

Meeting the Needs of Aging Persons. Aging in Individuals with a

Patients with dementia and other types of structural brain injury are predisposed to delirium (i.e., abrupt onset, temporary confusion caused by

How To Treat An Elderly Patient

Depression in the Elderly: Recognition, Diagnosis, and Treatment

Disclosure Statement. Nursing Facility Regulations and Psychotropic Medication Use. Learning Objectives (Cont) Learning Objectives

Drugs PSYCHOSIS. Depression. Stress Medical Illness. Mania. Schizophrenia

Dementa Formulary Guidance [v1.0]

New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery

North Bay Regional Health Centre

Update on Treatment of the Dementias

Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment

Psychiatric Comorbidity in Methamphetamine-Dependent Patients

Schizoaffective disorder

Chronic mental illness in LTCF. Chronic mental illness. Other psychiatric disorders.

Elizabeth A. Crocco, MD Assistant Clinical Professor Chief, Division of Geriatric Psychiatry Department of Psychiatry and Behavioral Sciences Miller

Memantine (Ebixa) Drug treatment for Alzheimer s disease

Washington State Regional Support Network (RSN)

NURSING B29 Gerontology Community Nursing. UNIT 2 Care of the Cognitively Impaired Elder in the Community

2. The prescribing clinician will register with the designated manufacturer.

Psychosis Psychosis-substance use Bipolar Affective Disorder Programmes EASY JCEP EPISO Prodrome

Donepezil hydrochloride (Aricept) Drug treatment for Alzheimer s disease

Lewy body dementia Referral for a Diagnosis

PARTNERING WITH YOUR DOCTOR:

Update on guidelines on biological treatment of depressive disorder. Dr. Henry CHEUNG Psychiatrist in private practice

Parkinson s Disease - A Junior Doctor s Survival Guide

ATYPICALS ANTIPSYCHOTIC MEDICATIONS

Professional Reference Series Depression and Anxiety, Volume 1. Depression and Anxiety Prevention for Older Adults

Schizophrenia. This factsheet provides a basic description of schizophrenia, its symptoms and the treatments and support options available.

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

ICD- 9 Source Description ICD- 10 Source Description

BIPOLAR DISORDER IN PRIMARY CARE

TREATING MAJOR DEPRESSIVE DISORDER

Nova Scotia Seniors Mental Health Assessment Toolkit

How To Safely Use Aripiprazole

Schizoaffective Disorder

The Clinical Presentation of Psychotic Disorders Bob Boland MD

Diagnosis and Initial Management of Cognitive Disorders

`çããçå=jéåí~ä= aáëçêçéêëw=^åñáéíó=~åç= aééêéëëáçå. aêk=`=f=lâçåü~ jéçáå~ä=aáêéåíçê lñäé~ë=kep=cçìåç~íáçå=qêìëí=

Dementia End-of-Life Care

Mental Health & Substance Use Disorders

Depression & Multiple Sclerosis

Parkinson s Disease and Dementia. Dr N Samaniego Consultant Physician and Geriatrician

How to identify, approach and assist employees with young onset dementia: A guide for employers

CHAPTER EIGHT SCHIZOPHRENIA AND BIPOLAR DISORDERS. Helping the Consumer Manage Schizophrenia and Bipolar Disorder

Definition of Terms. nn Mental Illness Facts and Statistics

Care Manager Resources: Common Questions & Answers about Treatments for Depression

Depression & Multiple Sclerosis. Managing Specific Issues

Background. Population/Intervention(s)/Comparator/Outcome(s) (PICO)

Evaluations. Viewer Call-In. Phone: Fax: Geriatric Mental Health. Thanks to our Sponsors: Guest Speaker

Electroconvulsive Therapy - ECT

North of Tyne Area Prescribing Committee

Step 4: Complex and severe depression in adults

adaptations whenever possible, to prevent or reduce the occurrence of challenging behaviours.

Dr Steve Moss BSc MSc Phd, Consultant Research Psychologist attached to the Estia Centre, Guys Hospital, London.

Dual diagnosis: working together

Presently, there are no means of preventing bipolar disorder. However, there are ways of preventing future episodes: 1

Behavioral Health Best Practice Documentation

Serious Mental Illness: Symptoms, Treatment and Causes of Relapse

[KQ 804] FEBRUARY 2007 Sub. Code: 9105

Assisted Living Nurse Competencies

CENTRAL NERVOUS SYSTEM MANAGEMENT OF PARKINSON S DISEASE

MEDGUIDE SECTION. What is the most important information I should know about SEROQUEL? SEROQUEL may cause serious side effects, including:

MANAGEMENT OF DIFFICULT BEHAVIORS IN DEMENTIA

Transcription:

PSYCHOSIS IN THE ELDERLY AN INTERACTIVE CASE-BASED TUTORIAL

REFERRAL You are a clinician working in geriatric psychiatry. A family physician sends you the following referral: Please see Ms. Dee, a 65 year old single female who lives alone in an apartment. She has been concerned about the upstairs neighbours, as she believes they are spying on her and stealing from her. There is no past psychiatric history. Your advice re assessment and treatment recommendations is appreciated. You arrange to see Ms. Dee and her niece in clinic.

WHAT IS THE DIFFERENTIAL DIAGNOSIS OF PSYCHOSIS IN THE ELDERLY? Dementia Major depression Delirium Medical conditions Mania Substance-induced (drugs/etoh/medications) Delusional disorder Schizophrenia

WHAT IS THE MOST COMMON ETIOLOGY? Dementia (40%) Major depression Delirium (7%) Medical conditions Mania (5%) Substance-induced (33%) (7%) (4%) Delusional disorder (2%) Schizophrenia (1%) Webster et al 1998

HISTORY You see Ms. Dee and obtain the following history. She believes the young couple upstairs might be spying on her. They know when she isn t home, and break in to look for valuables to buy drugs. She has no proof of this and has never caught them, but is convinced. She complains to the landlord, who has done nothing to help. She denies other delusions or hallucinations, and has no symptoms of depression or mania.

WHAT ARE YOUR NEXT STEP(S)? Obtain collateral Include premorbid personality Review medical history Include medications Medical investigations Rule out delirium Cognitive testing Rule out cognitive impairment

COLLATERAL You speak with her niece after getting informed consent from the patient. Over the past year, Ms. Dee has become obsessed with the upstairs neighbours. She believes they spy on her and have tried to steal from her, but has never called the police. Her beliefs continue to intensify, and she calls her niece weekly with these concerns. She doesn t have memory problems and is fully independent for ADLs and IADLs.

COLLATERAL Ms. Dee was never married, and retired from her secretarial job 10 years ago. She is socially isolated, and prefers the company of her cats. She has always been odd and eccentric, mistrustful of others, and has never gotten along with her neighbours. There is no FH of psychiatric illness.

MEDICAL HISTORY Bilateral hearing loss Refuses to wear hearing aid 40 pack year history of smoking and currently smokes No alcohol use Occasional tylenol use for headaches No other medications DO NOT FORGET TO INQUIRE ABOUT HERBAL OR OTHER ALTERNATIVE REMEDIES

WHAT MEDICAL INVESTIGATIONS WOULD YOU ORDER? CBC Electrolytes BUN/creatinine Glucose Calcium Magnesium Albumin Lipid profile ALT/AST/GGT TSH B12 Folate Urinalysis CT Head (WHY?)

TEST RESULTS Bloodwork normal Urinalysis normal CT Head Mild age-related atrophy No vascular changes

WHAT COGNITIVE TESTS WOULD YOU PERFORM? MMSE 30/30 Clock drawing Normal Frontal Assessment Battery 16/18

DEMENTIA? DOES MS. Dee HAVE DEMENTIA? NO WHY NOT? NO COGNITIVE IMPAIRMENT NO FUNCTIONAL IMPAIRMENT HER DELUSION IS COMPLEX

DELIRIUM? COULD THIS BE DELIRIUM? UNLIKELY WHY NOT? Symptoms are not transient No obvious medical cause Psychosis in delirium is different Misinterpretations, illusions, visual hallucinations are more common Delusions in delirium are different Usually transient, poorly systematized

DEPRESSION? COULD THIS BE DEPRESSION? THERE ARE NO DEPRESSIVE SYMPTOMS HOW COMMON IS PSYCHOSIS IN DEPRESSION IN THE ELDERLY? 36% - 45% have delusions Usually mood congruent Common themes of persecution, guilt, nihilism Has poorer prognosis Suicide attempts and relapse more common Treat with ECT

DIAGNOSIS? WHAT IS YOUR DIAGNOSIS? DELUSIONAL DISORDER WHY? Delusion is non-bizarre Duration is greater than 1 month Criterion A for schizophrenia not met Functioning not markedly impaired

DELUSIONAL DISORDER WHAT ARE THE DIFFERENT TYPES OF DELUSIONAL DISORDER? Erotomanic Grandiose Jealous Persecutory Somatic Mixed WHAT TYPE DOES MS. DEE HAVE?

You discuss the diagnosis of psychosis, specifically delusional disorder, with Ms. Dee s niece. She has several questions for you. She would like to know how common psychosis is, and what might cause it.

HOW COMMON IS PSYCHOSIS IN THE ELDERLY? Psychosis is more common in the elderly 16-23% have organic psychosis (ECA study) 4% of community-dwelling elderly have paranoia 17% in outpatient clinic have paranoia 50% of those with dementia have delusions and/or hallucinations Targum et al 1999

WHAT ARE RISK FACTORS FOR PSYCHOSIS IN THE ELDERLY? Female gender Cognitive impairment Co-morbid medical conditions Medications Especially if dopaminergic, anticholinergic Substance abuse Sensory deficits Social isolation Pre-morbid personality Especially if paranoid Genetic predisposition

WHICH RISK FACTORS DOES MS. LUSIONAL HAVE? Female gender Cognitive impairment Co-morbid medical conditions Medications Substance abuse Sensory deficits Social isolation Pre-morbid personality Genetic predisposition

DELUSIONAL DISORDER 0.03% population prevalence Age of onset varies with gender Male 40-49 Female 60-69 Non-bizarre delusion(s) Tactile or olfactory hallucinations may be present if related to the delusion Associated with pre-morbid personality Schizotypal, paranoid Associated with hearing loss, low socio-economic status, and immigration Resistant to treatment

WHAT IS THE COLLABORATIVE TREATMENT PLAN? NON-PHARMACOLOGICAL Suggest hearing aid Request home visit PHARMACOLOGICAL Antipsychotic medication Discontinue unnecessary medications

At the mention of antipsychotic medication, Ms. Dee decides she does not want to see the psychiatrist again. You instruct her niece to contact you if she has any further concerns or questions. You decide to attempt a home visit in 3 months.

RE-REFERRAL One year later, you are asked to see Ms. Dee again. She has been admitted to an inpatient unit. She now not only believes she is being spied on, but that the neighbours take her to the basement and perform tests. She shows you a bruise on her arm as proof. They release gas through a vent in the ceiling to knock her out, which she can smell. They have planted a chip in her head to monitor her location, and plan to harvest her organs. She can hear them through the walls, saying let s kill her. She is no longer bathing or eating. These symptoms began six months ago.

What do you want to do? Routine B/W Collateral from niece Any medical/medication changes Cognitive Testing

DIAGNOSIS? WHAT IS YOUR DIAGNOSIS? (consider that medical tests are still normal) LATE-ONSET SCHIZOPHRENIA WHY? Bizarre delusions Hallucinations Auditory, olfactory At least six month duration

SCHIZOPHRENIA IN THE ELDERLY Two possible subtypes > 40 Late Onset Schizophrenia (LOS) > 60 Very-Late-Onset Schizophrenia-Like Psychosis (VLOSP) Scarce epidemiological data 10%-23.5% of cases occur after age 40 > 65 community prevalence 0.1% - 0.5% Cause unknown?late-life stressors Bereavement, retirement, disability, etc?neuronal loss secondary to aging NO EVIDENCE IT IS A DEMENTING PROCESS

HOW IS LATE-ONSET SCHIZOPHRENIA (LOS) DIFFERENT FROM EARLY-ONSET SCHIZOPHRENIA (EOS)? More common in women Persecutory and partition delusions more common Less thought disorder Fewer negative symptoms Less family history Higher prevalence of sensory deficits Visual hallucinations may be more common Pre-morbid functioning less impaired

You need to support and educate around the psychiatrist s medication recommendations WHAT ARE THE MEDICATION OPTIONS? ANTIPSYCHOTICS Conventional High potency - haldol Medium potency - loxapine Low potency - chlorpromazine Atypical Clozapine Risperidone Olanzapine Quetiapine

WHAT SIDE EFFECTS WOULD YOU WORRY ABOUT IN THE ELDERLY? ANTICHOLINERGIC (be specific) Urinary retention Dry mouth Blurred vision Constipation Sinus tachycardia Confusion Seizures Sedation Weight gain Orthostatic hypotension EPSE Tardive dyskinesia

SIDE EFFECTS - CONVENTIONAL ANTIPSYCHOTICS LOW POTENCY (for eg. Chlorpromazine) Sedation Orthostatic hypotension Anticholinergic Decreased seizure threshold HIGH POTENCY (for eg. Haldol) EPSE Tardive dyskinesia

SIDE EFFECTS - ANTIPSYCHOTICS CLOZAPINE Anticholinergic Weight gain Sedation Salivation Orthostatic hypotension Seizure AGRANULOCYTOSIS MAY HELP TD RISPERIDONE Sedation ATYPICAL Orthostatic hypotension (least likely) EPSE (usually at higher doses)

SIDE EFFECTS - ANTIPSYCHOTICS OLANZAPINE Anticholinergic Dizziness Sedation Weight gain QUETIAPINE Sedation ATYPICAL Orthostatic hypotension Little to no EPSE/TD IS DOSING OF ANTIPSYCHOTICS DIFFERENT IN THE ELDERLY? YES REQUIRE LOWER DOSES (START LOW, GO SLOW, STAY LOW!)

TREATMENT RESPONSE Limited information on treatment response Open studies of conventional neuroleptics show 48%-61% have full remission Require lower dose than EOS patients Pre-morbid schizoid traits and thought disorder predict poor treatment response

TREATMENT Risperidone is started, and the dose is gradually titrated to 3 mg daily with good response. After two weeks of treatment at this dose, you notice Ms. Lusional has a resting tremor in her hands, and is walking slowly with decreased arm swing. WHAT IS HAPPENING? EPSE (Extrapyramidal side effects)

EPSE WHAT ARE EPSE? Pseudoparkinsonism Resting tremor Rigidity Bradykinesia Gait disorder (FALLS) Dyskinesia Dystonia Akathisia Elderly female are at highest risk

WHICH OF THE FOLLOWING OPTIONS WOULD YOU AVOID? DECREASE DOSE SWITCH MEDICATIONS ANTICHOLINERGICS WHAT WOULD YOU DO NOW?

You decide to decrease the dose of risperidone to 2mg daily. The extrapyramidal side effects improve and Ms. Dee is discharged home with close follow up by the senior s mental health team.

Approximately one year later, Ms. Dee reports strange mouth movements. You notice lateral writhing jaw and tongue movements that are continuous. WHAT IS THE LIKELY DIAGNOSIS? TARDIVE DYSKINESIA

TARDIVE DYSKINESIA (TD) IN THE ELDERLY HOW COMMON IS TD IN THE ELDERLY? Jeste et al 1999 Used conventional antipsychotics TD 5-6x more common in the elderly 29% at 1 year 50% at 2 years 63% at 3 years Up to 2.6% incidence of TD at 1 year with risperidone

TD RISK FACTORS Age Female WHAT ARE RISK FACTORS FOR TD? Cognitive impairment Pre-existing movement disorder Early EPSE Negative symptoms Mood disorder EtOH dependence Brain damage

TD IN THE ELDERLY HOW MAY TD BE PROBLEMATIC IN THE ELDERLY? Orofacial Eating difficulties Swallowing difficulties Choking Limbtruncal Gait difficulties Falls Embarrassment/stigma REMISSION IS LESS LIKELY IN THE ELDERLY

TD IN THE ELDERLY WHAT ARE YOUR TREATMENT OPTIONS? Medication withdrawal May have immediate worsening of TD May have relapse Medication increase Might suppress TD EPSE has already occurred at higher doses Clozapine Usually improves existing TD Side effects may be intolerable Switch to a different atypical

You decide to switch to quetiapine, and gradually titrate the dose to 200 mg hs while decreasing the dose of risperidone. The TD symptoms decrease, and Ms. Lusional s psychotic symptoms remain well controlled.

Three years later, you are asked to see Ms. Dee again. Her niece has called with concerns that her memory is not quite the same, and wonders if she has Alzheimer s Disease. She does not have any obvious psychotic symptoms.

WHAT COGNITIVE DEFICITS WOULD BE EXPECTED IN LOS? Similar pattern to those with EOS Executive dysfunction Motor skills Verbal ability Learning Memory and learning capacity are relatively spared in EOS compared to dementia

HOW WOULD YOU ASSESS FOR DEMENTIA? Cognitive assessment Consider neuropsychological testing Functional inquiry Assess IADL s/adl s Consider OT assessment if necessary Collateral Medical investigations TSH, B12, folate, etc.

After a thorough assessment with functional inquiry and cognitive testing, it appears Ms. Dee has Alzheimer s Disease. IS LATE-ONSET SCHIZOPHRENIA A RISK FACTOR FOR DEMENTIA? POSSIBLY Brodaty et al 2003 5 year follow up of LOS patients vs. controls 9 LOS patients (compared to 0 control patients) developed dementia

Ms. Dee is treated with a cholinesterase inhibitor, but eventually her memory and functioning worsen. She is no longer able to care for herself, and is admitted to a nursing home. Her symptoms of schizophrenia (complex persecutory delusions) are still effectively treated, but the staff note she becomes confused and agitated in late afternoon.

PSYCHOSIS IN DEMENTIA HOW DOES PSYCHOSIS IN DEMENTIA DIFFER FROM THAT OF LOS? Agitation and aggression are more common (behavioural disturbance) Paranoid beliefs are often simple, and less complex Visual hallucinations are more common Delusions must be differentiated from misperceptions due to cognitive impairment or sensory deficits

PSYCHOSIS IN DEMENTIA HOW COMMON IS PSYCHOSIS IN DEMENTIA? >50% in Alzheimer s Disease 34% delusions 28% hallucinations 44% agitation 24% verbal aggression 18% wandering Targum et al 1999

PSYCHOSIS IN DEMENTIA Dementia with Lewy Bodies 90% have visual hallucinations Typically well formed and detailed Vascular Dementia Up to 40% have delusions

Over time, the late afternoon confusion and agitation worsens, and Ms. Dee strikes another nursing home resident while waiting for dinner. The nursing staff call and ask for your help. WHAT ARE YOUR TREATMENT OPTIONS? NON-PHARMACOLOGICAL PHARMACOLOGICAL

WHAT ARE SOME NON- PHARMACOLOGICAL INTERVENTIONS? ROUTINES Predictable settings with rituals/repetition REDIRECTION Diffuse restlessness with tasks, exercise, offering of food, music, or old movies REASSURANCE Verbal and non-verbal reassurance of paranoid thoughts REORGANIZATION Simplify environment; concrete tasks with small steps RETENTION OF SKILLS Perform tasks if possible, and thank them REASSESSMENT Explore wishes and fears, confer with family RESTRUCTURING Environmental change to avoid noise, overcrowding, rushing, overstimulation, and ambiguity REEVALUTION Evaluate hearing/visual acuity, correct if necessary Khouzam et al 2005

WHAT PHARMACOLOGICAL APPROACHES COULD BE TAKEN? (keep in mind Ms. Dee already takes quetiapine 200 mg hs) Increase quetiapine dose Divide quetiapine dose eg 100 mg q1600h and q2000h This would medicate her at time of confusion Switch to different atypical Trazodone Memantine

Trazodone 50 mg q1600h is started. The nursing home also keeps Ms. Dee in her room until supper time to avoid overstimulation. Although still somewhat confused in late afternoon, she is less agitated with no further episodes of aggression.

The nursing home is so happy with your services, they ask you to see another gentlemen. Mr. Tipper is a 79 year old male with Parkinson s Disease. He has been having recurrent visual hallucinations of small rodents running into his room. His medications are levodopa and selegiline. He does not have significant cognitive impairment.

PSYCHOSIS IN PARKINSON S DISEASE HOW COMMON IS PSYCHOSIS IN PARKINSON S DISEASE? <10% of untreated PD patients 15-40% in those treated with medications Medications are dopaminergic Usually visual hallucinations Typically human or animal figures 5% have delusions plus hallucinations Persistent psychotic symptoms are associated with: Greater functional impairment Caregiver burden Earlier nursing home placement

RISK FACTORS FOR PSYCHOSIS IN PD Parkinson medications (dopaminergic) Older age Greater cognitive impairment Increasing severity Longer duration of disease Co-morbid depression Visual impairment Polypharmacy

TREATMENT HOW WOULD YOU TREAT THE VISUAL HALLUCINATIONS? Lower the dose of medications (or discontinue) if tolerated Atypical antipsychotics Quetiapine is first-line therapy Clozapine (in lower doses) for treatment refractory cases Avoid conventional antipsychotics Many patients have insight Only treat the psychotic symptoms if necessary

Mr. Tipper s is able to tolerate discontinuation of selegiline. The frequency of the hallucinations decreases and the nursing staff are pleased with the outcome. Congratulations on a job well done!

REFERENCES Brodaty et al. Long-term Outcome of Late-onset Schizophrenia: 5-year Follow-up Study. British Journal of Psychiatry 2003;183:213-219. Gauthier et al. Strategies for Continued Successful Treatment of Alzheimer s Disease: Switching Cholinesterase Inhibitors. Curr Med Res Opin 2003;19(8):707-714. Goldberg, R.J. Tardive Dyskinesia in Elderly Patients: An Update. J Am Med Dir Assoc 2003;4:S33- S42. Howard et al. Late-Onset Schizophrenia and Very-Late-Onset Schizophrenia-Like Psychosis: An International Consensus. Am J Psychiatry 2000;157:172-178. Jeste, D.V. Tardive Dyskinesia in Older Patients. J Clin Psychiatry;2000;61(suppl4):27-32. Karim et al. The Biology of Psychosis in Older People. J Geriatr Psychiatry Neurol 2003;16:207-212. Khouzam et al. Psychosis in Late Life: Evaluation and Management of Disorders Seen in Primary Care. Geriatrics 2005;60(Mar):26-33. Targum et al. Psychoses in the Elderly: A Spectrum of Disorders. J Clin Psychiatry 1999:60(suppl 8):4-10. Thorpe, L. The Treatment of Psychotic Disorders in Late Life. Can J Psychiatry 1997;42(suppl1):19S- 27S). Tune et al. Schizophrenia in Late Life. Psychiatr Clin N Am 2003;26:103-113. Webster et al. Late-Life Onset of Psychotic Symptoms. Am J Geriatr Psychiatry 1998;6:196-202. Weintraub et al. Psychiatric Complications in Parkinson Disease. Am J Geriatr Psychiatry 2005;13:844-851.